PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VERA vs. BOXE.L
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between VERA and BOXE.L is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

VERA vs. BOXE.L - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vera Therapeutics, Inc. (VERA) and Tritax EuroBox plc GBp (BOXE.L). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2025February
-24.31%
1.17%
VERA
BOXE.L

Key characteristics

Fundamentals

Market Cap

VERA:

$1.87B

BOXE.L:

€666.02M

EPS

VERA:

-$2.61

BOXE.L:

-€0.03

Total Revenue (TTM)

VERA:

$0.00

BOXE.L:

€21.08M

Gross Profit (TTM)

VERA:

$952.00K

BOXE.L:

€13.02M

EBITDA (TTM)

VERA:

-$103.90M

BOXE.L:

-€14.63M

Returns By Period


VERA

YTD

-29.98%

1M

-12.14%

6M

-24.31%

1Y

-33.54%

5Y*

N/A

10Y*

N/A

BOXE.L

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VERA vs. BOXE.L — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VERA
The Risk-Adjusted Performance Rank of VERA is 1212
Overall Rank
The Sharpe Ratio Rank of VERA is 1616
Sharpe Ratio Rank
The Sortino Ratio Rank of VERA is 1818
Sortino Ratio Rank
The Omega Ratio Rank of VERA is 1919
Omega Ratio Rank
The Calmar Ratio Rank of VERA is 55
Calmar Ratio Rank
The Martin Ratio Rank of VERA is 22
Martin Ratio Rank

BOXE.L
The Risk-Adjusted Performance Rank of BOXE.L is 7070
Overall Rank
The Sharpe Ratio Rank of BOXE.L is 7373
Sharpe Ratio Rank
The Sortino Ratio Rank of BOXE.L is 6969
Sortino Ratio Rank
The Omega Ratio Rank of BOXE.L is 7070
Omega Ratio Rank
The Calmar Ratio Rank of BOXE.L is 6767
Calmar Ratio Rank
The Martin Ratio Rank of BOXE.L is 7272
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

VERA vs. BOXE.L - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Vera Therapeutics, Inc. (VERA) and Tritax EuroBox plc GBp (BOXE.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for VERA, currently valued at -0.64, compared to the broader market-2.000.002.00-0.641.11
The chart of Sortino ratio for VERA, currently valued at -0.71, compared to the broader market-4.00-2.000.002.004.006.00-0.711.94
The chart of Omega ratio for VERA, currently valued at 0.91, compared to the broader market0.501.001.502.000.911.30
The chart of Calmar ratio for VERA, currently valued at -0.84, compared to the broader market0.002.004.006.00-0.840.59
The chart of Martin ratio for VERA, currently valued at -1.85, compared to the broader market-10.000.0010.0020.0030.00-1.854.73
VERA
BOXE.L


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
-0.64
1.11
VERA
BOXE.L

Dividends

VERA vs. BOXE.L - Dividend Comparison

Neither VERA nor BOXE.L has paid dividends to shareholders.


TTM202420232022202120202019
VERA
Vera Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%
BOXE.L
Tritax EuroBox plc GBp
5.06%5.06%7.95%7.54%4.21%4.31%3.41%

Drawdowns

VERA vs. BOXE.L - Drawdown Comparison


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-40.48%
-39.99%
VERA
BOXE.L

Volatility

VERA vs. BOXE.L - Volatility Comparison

Vera Therapeutics, Inc. (VERA) has a higher volatility of 25.61% compared to Tritax EuroBox plc GBp (BOXE.L) at 0.00%. This indicates that VERA's price experiences larger fluctuations and is considered to be riskier than BOXE.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%SeptemberOctoberNovemberDecember2025February
25.61%
0
VERA
BOXE.L

Financials

VERA vs. BOXE.L - Financials Comparison

This section allows you to compare key financial metrics between Vera Therapeutics, Inc. and Tritax EuroBox plc GBp. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. VERA values in USD, BOXE.L values in EUR
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab